What is Recursion Pharmaceuticals, Inc.'s net change in cash?

Recursion Pharmaceuticals, Inc. (RXRX) reported net change in cash of -$88.74M in Q1 2026.

How has Recursion Pharmaceuticals, Inc.'s net change in cash changed year-over-year?

Recursion Pharmaceuticals, Inc.'s net change in cash increased by 5.5% year-over-year, from -$93.87M to -$88.74M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Recursion Pharmaceuticals, Inc. RXRX Net Change in Cash

Net Change in Cash at other companies

AbCellera Biologics Inc.ABCL

-$51.45M-1,849%

Relay Therapeutics, Inc.RLAY

$120.57M+492%

Septerna, Inc.SEPN

-$49.12M-74.5%

AnaptysBio, Inc.ANAB

$10.27M+142%

Erasca, Inc.ERAS

-$26.55M-1,068%

Rapport Therapeutics, Inc.RAPP

$25.41M+3,080%

Other financials

Income statement

See full

Revenue$6.5M-56.1%

Gross profit-$6.0M+15.0%

Operating income-$128.5M+32.8%

Net income-$117.5M+42.0%

EPS (diluted)-$0.22+56.0%

Balance sheet

See full

Cash & equivalents$665.2M+30.6%

Total debt$88.6M-24.6%

Total equity$1.0B+9.7%

Total assets$1.3B+2.6%

Cash flow

See full

Operating cash flow-$81.1M+38.5%

CapEx$258.0K-85.9%

Free cash flow-$81.4M+39.2%

Valuation

See full

Market cap$1.71B-23.7%

Profitability

See full

Gross margin7.2%—

Operating margin-881.3%-66.8pp

Net margin-842.9%-92.4pp

FCF margin-490.7%-102pp

Returns & leverage

See full

Return on equity-57.2%-14.4pp

Debt / equity0.1×0.0×

Current ratio5.5×+1.4×

Where this comes from

Reported directly by Recursion Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s net change in cash?: Recursion Pharmaceuticals, Inc. (RXRX) reported net change in cash of -$88.74M in Q1 2026.
How has Recursion Pharmaceuticals, Inc.'s net change in cash changed year-over-year?: Recursion Pharmaceuticals, Inc.'s net change in cash increased by 5.5% year-over-year, from -$93.87M to -$88.74M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.